{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:26:35Z","timestamp":1792783595462,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Suzhou Science and Technology Development","award":["201578"],"award-info":[{"award-number":["201578"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbi.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:51:08Z","timestamp":1559411468000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder"],"prefix":"10.1016","volume":"81","author":[{"given":"Ruihua","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.06.001_b0010","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","article-title":"Gut permeability and microbiota in Parkinson's Disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbi.2019.06.001_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1301606","article-title":"Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis","author":"Ben Menachem-Zidon","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2019.06.001_b0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1073\/pnas.0438019100","article-title":"A mechanism converting psychosocial stress into mononuclear cell activation","volume":"100","author":"Bierhaus","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.06.001_b0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0447.2005.00684.x","article-title":"Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries","volume":"113","author":"Buist-Bouwman","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2019.06.001_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7854_2016_6","article-title":"Role of the Kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches","volume":"31","author":"Dantzer","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.001_b0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1291\/hypres.30.285","article-title":"Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk","volume":"30","author":"Dawood","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbi.2019.06.001_b0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.2002.tb04229.x","article-title":"Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity","volume":"966","author":"Elenkov","year":"2002","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.bbi.2019.06.001_b0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.1014","article-title":"Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients","volume":"24","author":"Galecki","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.06.001_b0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbi.2010.10.013","article-title":"Citalopram reduces endotoxin-induced fatigue","volume":"25","author":"Hannestad","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7150\/ijms.7.224","article-title":"Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression","volume":"7","author":"He","year":"2010","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbi.2019.06.001_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","article-title":"Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study","volume":"62","author":"Hou","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0075","article-title":"Effects of SSRIs on inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis","author":"Hou","year":"2017","journal-title":"J. Psychopharmacol. Suppl."},{"key":"10.1016\/j.bbi.2019.06.001_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000351965","article-title":"Potential neuroimmunological targets in the treatment of anxiety disorders","volume":"29","author":"Hou","year":"2013","journal-title":"Modern Trends Pharmacopsychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hup.1259","article-title":"A neuroimmunological perspective of anxiety disorders","volume":"27","author":"Hou","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.06.001_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001848.pub4","article-title":"Psychological therapies for generalised anxiety disorder","author":"Hunot","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbi.2019.06.001_b0095","first-page":"Cd003592","article-title":"Antidepressants for generalized anxiety disorder","author":"Kapczinski","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbi.2019.06.001_b0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0889-1591(02)00069-7","article-title":"An interdisciplinary research model to investigate psychosocial cofactors in disease: application to HIV-1 pathogenesis","volume":"17","author":"Kemeny","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.0708092105","article-title":"IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress","volume":"105","author":"Koo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.06.001_b0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/JGP.0b013e3181ec806c","article-title":"Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram","volume":"19","author":"Lenze","year":"2011","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3928\/0090-4481-20010301-09","article-title":"Obsessive-compulsive disorder and related conditions","volume":"30","author":"Leonard","year":"2001","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.bbi.2019.06.001_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hup.1011","article-title":"The psychoneuroimmunology of depression","volume":"24","author":"Leonard","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.06.001_b0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","article-title":"Oxidative stress, inflammation and treatment response in major depression","volume":"76","author":"Lindqvist","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2019.06.001_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000119472","article-title":"Immune disturbances during major depression: upregulated expression of interleukin-2 receptors","volume":"24","author":"Maes","year":"1990","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbi.2019.06.001_b0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","article-title":"Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production","volume":"84","author":"Maes","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2019.06.001_b0150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","article-title":"Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness","volume":"16","author":"Maes","year":"1992","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0447.1992.tb03292.x","article-title":"Immune disorders in depression: higher T helper\/T suppressor-cytotoxic cell ratio","volume":"86","author":"Maes","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2019.06.001_b0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/cyto.1997.0290","article-title":"The effect of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety","volume":"10","author":"Maes","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2019.06.001_b0170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00019053-200826100-00005","article-title":"Multiple sclerosis in the UK: service use, costs, quality of life and disability","volume":"26","author":"McCrone","year":"2008","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.bbi.2019.06.001_b0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","article-title":"Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface","volume":"23","author":"Miller","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbi.2009.08.009","article-title":"Anger and fear responses to stress have different biological profiles","volume":"24","author":"Moons","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.bp.105.011015","article-title":"Antidepressant therapy and C-reactive protein levels","volume":"188","author":"O'Brien","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0190","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbi.2010.03.003","article-title":"Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships","volume":"24","author":"O'Donovan","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0195","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.4049\/jimmunol.178.9.5701","article-title":"Trafficking to human mast cell granules: mature chain-dependent endocytosis","volume":"178","author":"Olszewski","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.001_b0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2009.04984.x","article-title":"Cytokines and glucocorticoid receptor signaling. Relevance to major depression","volume":"1179","author":"Pace","year":"2009","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.bbi.2019.06.001_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2009.04978.x","article-title":"Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids","volume":"1179","author":"Pariante","year":"2009","journal-title":"Ann. NY. Acad. Sci."},{"key":"10.1016\/j.bbi.2019.06.001_b0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S204579601500089X","article-title":"Neuroscience, mental health and the immune system: overcoming the brain-mind-body trichotomy","volume":"25","author":"Pariante","year":"2016","journal-title":"Epidemiol. Psychiatric Sci."},{"key":"10.1016\/j.bbi.2019.06.001_b0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.euroneuro.2017.04.001","article-title":"Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation","volume":"27","author":"Pariante","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2019.06.001_b0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0225","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13075-014-0504-2","article-title":"The sympathetic nervous response in inflammation","volume":"16","author":"Pongratz","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbi.2019.06.001_b0230","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","article-title":"Interferon-alpha effects on diurnal hypothalamic\u2013pituitary\u2013adrenal axis activity: relationship with proinflammatory cytokines and behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 20","key":"10.1016\/j.bbi.2019.06.001_b9005","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2019.06.001_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111665","article-title":"Sertraline reduces IL-1beta and TNF-alpha mRNA expression and overcomes their rise induced by seizures in the rat hippocampus","volume":"9","author":"Sitges","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.06.001_b0240","series-title":"State-Trait Anxiety Inventory. A Comprehensive Bibliography","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.bbi.2019.06.001_b0245","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbi.2019.06.001_b0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jad.2017.08.082","article-title":"Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder","volume":"225","author":"Tang","year":"2018","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.bbi.2019.06.001_b0255","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.bbi.2010.07.247","article-title":"Neural aspects of immunomodulation: focus on the vagus nerve","volume":"24","author":"Thayer","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijcard.2008.02.013","article-title":"Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels","volume":"134","author":"Tousoulis","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbi.2019.06.001_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2019.02.021","article-title":"Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis","author":"Wang","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.001_b0270","first-page":"344","article-title":"Association between parenting styles and anxiety level in adolescence","volume":"14","author":"Wang","year":"2000","journal-title":"J. Chin. Ment. Health"},{"key":"10.1016\/j.bbi.2019.06.001_b0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2019.06.001_b9010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hup.2333","article-title":"Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder","volume":"28","author":"Yoshimura","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119301552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119301552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:58:46Z","timestamp":1760169526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119301552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":55,"alternative-id":["S0889159119301552"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.06.001","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}